Brought to you by 
Arrow gets EP mapping rights from Cardiac Pathways
13 Jul 1999
Executive Summary
Arrow (disposable catheters) agreed to invest $9 million in convertible preferred stock of Cardiac Pathways, a company focused on the development of new technology for treating cardiac tachyarrhythmias.
Deal Industry
- Medical Devices
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com